Plx Pharma Inc. (PLXP) SEC Filing 8-K Material Event for the period ending Tuesday, April 28, 2020

Plx Pharma Inc.

CIK: 1497504 Ticker: PLXP

View differences made from one to another to evaluate Plx Pharma Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Plx Pharma Inc..


Assess how Plx Pharma Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Plx Pharma Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: PLXP
CIK: 1497504
Form Type: 8-K Corporate News
Accession Number: 0000921895-20-001269
Submitted to the SEC: Mon May 04 2020 4:00:34 PM EST
Accepted by the SEC: Mon May 04 2020
Period: Tuesday, April 28, 2020
Industry: Pharmaceutical Preparations
  1. Listing Status

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: